Analysis of Hospitalizations for COPD Exacerbation: Opportunities for Improving Care
- 16 April 2010
- journal article
- research article
- Published by Informa UK Limited in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 7 (2), 85-92
- https://doi.org/10.3109/15412551003631683
Abstract
Little is known about the actual treatment of patients with chronic obstructive pulmonary disease (COPD), either in the inpatient or outpatient settings. We hypothesized that there are substantial opportunities for improvement in adherence with current guidelines and recommendations. We reviewed the medical records of all patients hospitalized with acute exacerbation of COPD between January 2005 and December 2006 at 5 New York City hospitals. There were 1285 unique patients with 1653 hospitalizations. Of these 1653, 83% were for patients with a prior history of COPD and 368 (22%) represented repeat admissions during our study period. The majority were treated during their hospitalization with a combination of systemic steroids (85%), bronchodilators (94%) and antibiotics (80%). There were 59 deaths (3.6%). Smoking cessation counseling was offered to 48% of active smokers. Influenza and pneumococcal vaccines were administered to half of eligible patients. On discharge, only 46.0% were prescribed maintenance bronchodilators and 24% were not prescribed any inhaled therapy. Even in the 226 unique patients (17.6%) readmitted at least once during course of the study, on discharge only 44.7% were prescribed maintenance bronchodilators and 23% were not prescribed any regular inhaled therapy. Patients hospitalized with acute exacerbation of COPD generally receive adequate hospital care, but there may be opportunities to improve care pharmacologically and with smoking cessation counseling and vaccination during and after hospitalization.Keywords
This publication has 43 references indexed in Scilit:
- The Epidemiology and Economics of Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2007
- Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2007
- Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Chronic Obstructive Pulmonary Disease: From Unjustified Nihilism to Evidence-based OptimismProceedings of the American Thoracic Society, 2006
- Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2003
- Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations.European Respiratory Journal, 2003
- The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trialsAmerican Journal Of Medicine, 2002
- Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published EvidenceAnnals of Internal Medicine, 2001
- Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ, 2000
- Continuous or Nocturnal Oxygen Therapy in Hypoxemic Chronic Obstructive Lung DiseaseAnnals of Internal Medicine, 1980